Kering SA
F:PPXB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kering SA
F:PPXB
|
FR |
|
A
|
Abbvie Inc
F:4AB
|
US |
|
Orix Corp
F:OIX
|
JP |
|
J
|
JMT Network Services PCL
SET:JMT
|
TH |
|
P
|
Plant Health Care PLC
F:PC5
|
US |
|
H
|
HSBC Holdings PLC
F:HBC2
|
UK |
|
Vianet Group PLC
F:AS2
|
UK |
|
W
|
Wells Fargo & Co
DUS:NWT
|
US |
|
F
|
Firstcash Holdings Inc
F:FF6
|
US |
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
M
|
Manulife Financial Corp
F:MLU
|
CA |
Wall St Price Targets
PPXB Price Targets Summary
Kering SA
According to Wall Street analysts, the average 1-year price target for PPXB is 28.48 EUR with a low forecast of 18.54 EUR and a high forecast of 40.57 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PPXB's stock price target?
Price Target
28.48
EUR
According to Wall Street analysts, the average 1-year price target for PPXB is 28.48 EUR with a low forecast of 18.54 EUR and a high forecast of 40.57 EUR.
What is the Revenue forecast for Kering SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for Kering SA?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 16%.
What is the Net Income forecast for Kering SA?
Projected CAGR
65%
Over the last 14 years, the compound annual growth rate for Net Income has been -17%. The projected CAGR for the next 8 years is 65%.
